{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:54:24Z","timestamp":1787676864816,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31902287"],"award-info":[{"award-number":["31902287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803575"],"award-info":[{"award-number":["81803575"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan Medical Science and Technology Research Program Project"},{"name":"College Students Innovation and Entrepreneurship Training Program of Henan University"},{"name":"Program for Innovative Talents of Science and Technology in Henan Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2024,10,19]]},"DOI":"10.1038\/s41416-024-02811-7","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T13:34:12Z","timestamp":1724420052000},"page":"1212-1223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["DRD4 promotes chemo-resistance and cancer stem cell-like phenotypes by mediating the activation of the Akt\/\u03b2-catenin signaling axis in liver cancer"],"prefix":"10.1038","volume":"131","author":[{"given":"Zhengyan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-5334","authenticated-orcid":false,"given":"Zhiguang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daxiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"2811_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598\u2013606.","journal-title":"J Hepatol"},{"key":"2811_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.188314","volume":"1873","author":"D Anwanwan","year":"2020","unstructured":"Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020;1873:188314.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2811_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.semcancer.2017.02.011","volume":"44","author":"C Peitzsch","year":"2017","unstructured":"Peitzsch C, Tyutyunnykova A, Pantel K, Dubrovska A. Cancer stem cells: the root of tumor recurrence and metastases. Semin Cancer Biol. 2017;44:10\u201324.","journal-title":"Semin Cancer Biol"},{"key":"2811_CR4","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3390\/cells9061331","volume":"9","author":"YC Liu","year":"2020","unstructured":"Liu YC, Yeh CT, Lin KH. Cancer stem cell functions in hepatocellular carcinoma and comprehensive therapeutic strategies. Cells. 2020;9:1331.","journal-title":"Cells"},{"key":"2811_CR5","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/0024-3205(78)90102-9","volume":"23","author":"L Garau","year":"1978","unstructured":"Garau L, Govoni S, Stefanini E, Trabucchi M, Spano PF. Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci. 1978;23:1745\u201350.","journal-title":"Life Sci"},{"key":"2811_CR6","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","volume":"149","author":"E Sachlos","year":"2012","unstructured":"Sachlos E, Risueno RM, Laronde S, Shapovalova Z, Lee JH, Russell J, et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell. 2012;149:1284\u201397.","journal-title":"Cell"},{"key":"2811_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ygyno.2010.10.003","volume":"120","author":"SB Rho","year":"2011","unstructured":"Rho SB, Kim BR, Kang S. A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3\u2019-kinase (PI3K)\/AKT pathway in ovarian cancer cells. Gynecol Oncol. 2011;120:121\u20137.","journal-title":"Gynecol Oncol"},{"key":"2811_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.77","volume":"6","author":"HW Cheng","year":"2015","unstructured":"Cheng HW, Liang YH, Kuo YL, Chuu CP, Lin CY, Lee MH, et al. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. Cell Death Dis. 2015;6:e1753.","journal-title":"Cell Death Dis"},{"key":"2811_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ccell.2016.05.002","volume":"29","author":"S Dolma","year":"2016","unstructured":"Dolma S, Selvadurai HJ, Lan X, Lee L, Kushida M, Voisin V, et al. Inhibition of dopamine receptor d4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells. Cancer Cell. 2016;29:859\u201373.","journal-title":"Cancer Cell"},{"key":"2811_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s12282-015-0658-z","volume":"23","author":"ME Akbari","year":"2016","unstructured":"Akbari ME, Kashani FL, Ahangari G, Pornour M, Hejazi H, Nooshinfar E, et al. The effects of spiritual intervention and changes in dopamine receptor gene expression in breast cancer patients. Breast Cancer. 2016;23:893\u2013900.","journal-title":"Breast Cancer"},{"key":"2811_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.lungcan.2006.11.007","volume":"56","author":"D Campa","year":"2007","unstructured":"Campa D, Zienolddiny S, Lind H, Ryberg D, Skaug V, Canzian F, et al. Polymorphisms of dopamine receptor\/transporter genes and risk of non-small cell lung cancer. Lung Cancer. 2007;56:17\u201323.","journal-title":"Lung Cancer"},{"key":"2811_CR12","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00262-020-02816-0","volume":"70","author":"Q Liu","year":"2021","unstructured":"Liu Q, Zhang R, Zhang X, Liu J, Wu H, Li Y, et al. Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. Cancer Immunol Immunother. 2021;70:2165\u201377.","journal-title":"Cancer Immunol Immunother"},{"key":"2811_CR13","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1002\/cam4.5420","volume":"12","author":"CJ Lee","year":"2023","unstructured":"Lee CJ, Baek B, Cho SH, Jang TY, Jeon SE, Lee S, et al. Machine learning with in silico analysis markedly improves survival prediction modeling in colon cancer patients. Cancer Med. 2023;12:7603\u201315.","journal-title":"Cancer Med"},{"key":"2811_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1200017","volume":"14","author":"J Chen","year":"2023","unstructured":"Chen J, Wu S, Peng Y, Zhao Y, Dong Y, Ran F, et al. Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer. Front Pharm. 2023;14:1200017.","journal-title":"Front Pharm"},{"key":"2811_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/jgh.16040","volume":"38","author":"Z Yang","year":"2023","unstructured":"Yang Z, Wan W, Zhang P, Wang S, Zhao Z, Xue J, et al. Crosstalk between heat shock factor 1 and signal transducer and activator of transcription 3 mediated by interleukin-8 autocrine signaling maintains the cancer stem cell phenotype in liver cancer. J Gastroenterol Hepatol. 2023;38:138\u201352.","journal-title":"J Gastroenterol Hepatol"},{"key":"2811_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5:8.","journal-title":"Signal Transduct Target Ther"},{"key":"2811_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.stem.2015.03.003","volume":"16","author":"W Yanying","year":"2015","unstructured":"Yanying W, Lei H, Ying D, Pingping Z, Guanling H, Jianjun L, et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell. 2015;16:413\u201325.","journal-title":"Cell Stem Cell"},{"key":"2811_CR18","doi-asserted-by":"publisher","first-page":"11221","DOI":"10.1074\/jbc.M611871200","volume":"282","author":"D Fang","year":"2007","unstructured":"Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, et al. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem. 2007;282:11221\u20139.","journal-title":"J Biol Chem"},{"key":"2811_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.biocel.2019.05.004","volume":"112","author":"G Amable","year":"2019","unstructured":"Amable G, Martinez-Leon E, Picco ME, Di Siervi N, Davio C, Rozengurt E, et al. Metformin inhibits beta-catenin phosphorylation on Ser-552 through an AMPK\/PI3K\/Akt pathway in colorectal cancer cells. Int J Biochem Cell Biol. 2019;112:88\u201394.","journal-title":"Int J Biochem Cell Biol"},{"key":"2811_CR20","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1136\/gutjnl-2014-307191","volume":"64","author":"M Soutto","year":"2015","unstructured":"Soutto M, Peng D, Katsha A, Chen Z, Piazuelo MB, Washington MK, et al. Activation of beta-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis. Gut. 2015;64:1028\u201339.","journal-title":"Gut"},{"key":"2811_CR21","first-page":"1303","volume":"123","author":"T Bekaii-Saab","year":"2017","unstructured":"Bekaii-Saab T, El-Rayes B. Identifying and targeting cancer stem cells in the treatment of gastric cancer. Cancer Am Cancer Soc. 2017;123:1303\u201312.","journal-title":"Cancer Am Cancer Soc"},{"key":"2811_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-018-0568-6","volume":"11","author":"J Li","year":"2018","unstructured":"Li J, Li W, Huang K, Zhang Y, Kupfer G, Zhao Q. Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward. J Hematol Oncol. 2018;11:22.","journal-title":"J Hematol Oncol"},{"key":"2811_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-016-0378-7","volume":"10","author":"KC Feng","year":"2017","unstructured":"Feng KC, Guo YL, Liu Y, Dai HR, Wang Y, Lv HY, et al. Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma. J Hematol Oncol. 2017;10:4.","journal-title":"J Hematol Oncol"},{"key":"2811_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ccell.2017.02.005","volume":"31","author":"B Boilly","year":"2017","unstructured":"Boilly B, Faulkner S, Jobling P, Hondermarck H. Nerve dependence: from regeneration to cancer. Cancer Cell. 2017;31:342\u201354.","journal-title":"Cancer Cell"},{"key":"2811_CR25","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/2159-8290.CD-18-1398","volume":"9","author":"S Faulkner","year":"2019","unstructured":"Faulkner S, Jobling P, March B, Jiang CC, Hondermarck H. Tumor neurobiology and the war of nerves in cancer. Cancer Discov. 2019;9:702\u201310.","journal-title":"Cancer Discov"},{"key":"2811_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.aah5072","volume":"358","author":"AH Zahalka","year":"2017","unstructured":"Zahalka AH, Estape AA, Maryanovich M, Nakahara F, Cruz CD, Finley L, et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science. 2017;358:321\u20136.","journal-title":"Science"},{"key":"2811_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.stem.2015.02.006","volume":"16","author":"SC Peterson","year":"2015","unstructured":"Peterson SC, Eberl M, Vagnozzi AN, Belkadi A, Veniaminova NA, Verhaegen ME, et al. Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches. Cell Stem Cell. 2015;16:400\u201312.","journal-title":"Cell Stem Cell"},{"key":"2811_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2016.11.005","volume":"31","author":"Y Hayakawa","year":"2017","unstructured":"Hayakawa Y, Sakitani K, Konishi M, Asfaha S, Niikura R, Tomita H, et al. Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling. Cancer Cell. 2017;31:21\u201334.","journal-title":"Cancer Cell"},{"key":"2811_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/1523-1747.ep12543559","volume":"70","author":"MM Wick","year":"1978","unstructured":"Wick MM, Kramer RA, Gorman M. Enhancement of L-dopa incorporation into melanoma by dopa decarboxylase inhibition. J Invest Dermatol. 1978;70:358\u201360.","journal-title":"J Invest Dermatol"},{"key":"2811_CR30","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3390\/cancers11101442","volume":"11","author":"YT Wen","year":"2019","unstructured":"Wen YT, Wu AT, Bamodu OA, Wei L, Lin CM, Yen Y, et al. A novel multi-target small molecule, LCC-09, inhibits stemness and therapy-resistant phenotypes of glioblastoma cells by increasing miR-34a and deregulating the DRD4\/Akt\/mTOR signaling axis. Cancers (Basel). 2019;11:1442.","journal-title":"Cancers (Basel)"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02811-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02811-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02811-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T16:03:54Z","timestamp":1727712234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02811-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10,19]]}},"alternative-id":["2811"],"URL":"https:\/\/doi.org\/10.1038\/s41416-024-02811-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"21 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experiments involving animal studies and patient specimens were reviewed and approved by the Ethics Committee of the Medical School of Henan University (HUSOM2023-221 and HUSOM2023-222). Informed consent was obtained from all participants involved in the study. All authors agree with the content of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}